Alternatives to AlterEcho

Develops, manufactures, and markets radiopharmaceuticals for diagnostic and therapeutic applications.

Developing autonomous robotic phlebotomy devices to standardize blood collection and improve patient care.

Robotics and AI company developing rehabilitation solutions for neurological and mobility impairments.

International specialty pharmaceutical company focused on central nervous system, pain management, and addiction treatments.

A leading global contract development and manufacturing organization (CDMO) for innovative biologic and small molecule therapies.

Developing ultra-high bandwidth brain-machine interfaces to connect humans and computers.

Pharma company

Geek+ is a global leader in autonomous mobile robots (AMRs) for warehouse and logistics automation.

Augmedics uses augmented reality to provide surgeons with 'x-ray vision' for spine procedures.

Azurity Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing high-quality, affordable liquid medications.

Developing AI-powered robot foundation models for autonomous operation in real-world industrial environments.

Velaura AI develops ultra-low power silicon and software technologies for AI infrastructure, focusing on energy efficiency for data centers and physical AI applications.

Aurora Innovation develops the Aurora Driver, a self-driving system for autonomous trucks and ride-hailing vehicles.

Global musculoskeletal solutions company developing implants, robotics, and enabling technologies for spine and orthopedic procedures.

AI-powered platform for designing, programming, and deploying robotic automation cells.

A global leader in healthcare, developing innovative solutions for consumer health, pharmaceuticals, and medical devices.

Autonomous vehicle technology company developing self-driving systems for ride-sharing.

Developing the first robotic surgery platform for cataracts and widespread eye diseases.

Building foundational world models for AI systems that understand and interact with the physical world

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).